Frank Witney

CIK 1455312 · President and CEO · last filed 2026-06-23

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$3.97M

Companies

9

Total Filings

70

Lifetime Open-Market Net

-$2.52M

Filer Profile

Reported Address
77 4TH AVENUE
C/O REVVITY
WALTHAM, MA 02451-7567
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LAB Director 314,203 $0.69 $216.8K $0 6 2026-06-23
CERS Director 340,059 $2.49 $846.7K $137.8K 19 2026-06-02
RVTY Director 23,354 $124.31 $2.90M $0 4 2026-05-11
ALMR Director $27.89 $0 1 2026-04-20
Telesis Bio Inc. (TBIO) Delisted Director 6,430 $0.00 $1 $0 1 2024-05-03
Telesis Bio Inc. (DNAY) Delisted Director 20,630 $1.30 $26.8K $0 1 2022-06-13
REVVITY, INC. (PKI) Delisted Director 14,729 $115.24 $1.70M $0 7 2022-05-09
AFFYMETRIX INC (AFFX) Delisted President and CEO 0 -$2.66M 29 2016-04-01
DIONEX CORP /DE (DNEX) Delisted President and CEO $0 1 2010-08-05

Recent Filings · Page 2 of 7

70 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2024-05-03 Telesis Bio Inc. (TBIO) Delisted Grant (A) +95,106 $0 EDGAR
2024-05-02 RVTY Grant (A) +2,195 $0 EDGAR
2023-06-16 LAB Grant (A) +26,376 $0 EDGAR
2023-06-09 CERS Grant (A) +40,000 $200.0K EDGAR
2023-05-17 RVTY Grant (A) +1,738 $0 EDGAR
2022-06-17 LAB Grant (A) +30,914 $0 EDGAR
2022-06-13 Telesis Bio Inc. (DNAY) Delisted Grant (A) +20,630 $0 EDGAR
2022-06-03 CERS Grant (A) +20,454 $0 EDGAR
2022-05-09 REVVITY, INC. (PKI) Delisted Grant (A) +1,354 $0 EDGAR
2022-04-06 LAB Grant (A) +15,852 $0 EDGAR
Showing 1120 of 70
Page 2 of 7
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.